My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Long term immunologic consequences of experimental stroke and mucosal tolerance.

    Gee JM, Zierath D, Hadwin J, Savos A, Kalil A, Thullbery M, Becker KJ.

    Exp Transl Stroke Med. 2009 Oct 21;1:3.PMID: 20142990 [PubMed]Free PMC ArticleFree textRelated citations

    2.

    Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.

    Gee JM, Kalil A, Thullbery M, Becker KJ.

    Stroke. 2008 May;39(5):1575-82. Epub 2008 Mar 6.PMID: 18323496 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    3.

    Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?

    Becker K, Kindrick D, McCarron R, Hallenbeck J, Winn R.

    Stroke. 2003 Jul;34(7):1809-15. Epub 2003 Jun 5.PMID: 12791945 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    4.

    CNS immune responses following experimental stroke.

    Zierath D, Thullbery M, Hadwin J, Gee JM, Savos A, Kalil A, Becker KJ.

    Neurocrit Care. 2010 Apr;12(2):274-84. Epub 2009 Aug 28.PMID: 19714497 [PubMed - indexed for MEDLINE]Related citations

    6.

    Sensitization to brain antigens after stroke is augmented by lipopolysaccharide.

    Becker KJ, Kindrick DL, Lester MP, Shea C, Ye ZC.

    J Cereb Blood Flow Metab. 2005 Dec;25(12):1634-44.PMID: 15931160 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    7.

    Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.

    Becker KJ, McCarron RM, Ruetzler C, Laban O, Sternberg E, Flanders KC, Hallenbeck JM.

    Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10873-8.PMID: 9380727 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    8.

    Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.

    Bai XF, Shi FD, Xiao BG, Li HL, van der Meide PH, Link H.

    J Neuroimmunol. 1997 Dec;80(1-2):65-75.PMID: 9413260 [PubMed - indexed for MEDLINE]Related citations

    9.

    Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.

    Li HL, Liu JQ, Bai XF, vn der Meide PH, Link H.

    Immunology. 1998 Jul;94(3):431-7.PMID: 9767428 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    10.

    Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.

    Liu JQ, Bai XF, Shi FD, Xiao BG, Li HL, Levi M, Mustafa M, Wahren B, Link H.

    Int Immunol. 1998 Aug;10(8):1139-48.PMID: 9723700 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    12.

    Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats.

    Takeda H, Spatz M, Ruetzler C, McCarron R, Becker K, Hallenbeck J.

    Stroke. 2002 Sep;33(9):2156-63.PMID: 12215580 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    14.

    Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury.

    Chen Y, Ruetzler C, Pandipati S, Spatz M, McCarron RM, Becker K, Hallenbeck JM.

    Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15107-12. Epub 2003 Nov 26.PMID: 14645708 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    15.

    Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.

    Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA Jr, Weiner HL.

    Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):388-91.PMID: 8552644 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    16.
    17.

    Reduced experimental autoimmune encephalomyelitis after intranasal and oral administration of recombinant lactobacilli expressing myelin antigens.

    Maassen CB, Laman JD, van Holten-Neelen C, Hoogteijling L, Groenewegen L, Visser L, Schellekens MM, Boersma WJ, Claassen E.

    Vaccine. 2003 Dec 1;21(32):4685-93.PMID: 14585676 [PubMed - indexed for MEDLINE]Related citations

    18.

    Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.

    Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA.

    J Clin Invest. 1996 Jul 1;98(1):70-7.PMID: 8690806 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    19.

    Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats.

    Malotky MK, Pope L, Miller SD.

    J Immunol. 1994 Jul 15;153(2):841-51.PMID: 7517425 [PubMed - indexed for MEDLINE]Related citations

    20.

    Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.

    Miller A, al-Sabbagh A, Santos LM, Das MP, Weiner HL.

    J Immunol. 1993 Dec 15;151(12):7307-15.PMID: 7505026 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk